Brucellosis is an important zoonotic disease causing significant economic losses worldwide. Early detection of this disease is essential for its control and eradication. Presently, an Indirect Enzyme Linked Immunosorbent Assay (I-ELISA) was developed using lipopolysaccharide (LPS) as antigen and compared with the commercial kit using one hundred negative and positive sera each from buffaloes. The agreement for the positive result between the developed and commercial I-ELISA was 78% and for the negative it was 100%. At 52.49%, 53.09%, 53.26%, 53.86% and 53.94% cut off the sensitivity was 100%, 100%, 97.53%, 88.93% and 86.42%, while the specificity was 84.03%, 84.87%, 85.71%, 87.39% and 87.39%, respectively, for developed I-ELISA. This developed test can be used for the screening of herds as the relative sensitivity is higher.
Brucellosis is a highly contagious, zoonotic and economically important bacterial disease of animals worldwide (OIE 2000) . The disease is caused by various species of the genus Brucella, which are facultative, intracellular bacteria capable of surviving and multiplying inside the cells of mononuclear phagocytic system (Jarvis et al. 2002) . The disease causes significant economic losses including abortion, loss in milk production, low fertility rates and cost of replacement of animals (McDermott and Arimi 2002) . Timely diagnosis of the disease in sexually mature animals is very important and necessary for the control of this malady; also the transmission of the disease to humans is an important justification to undertake measures for its control and eradication.
Early detection, control and elimination of reactors are important considerations for the control of brucellosis. Brucellosis is diagnosed by classical serological techniques i.e., agglutination, precipitation, complement fixation but these techniques have several drawbacks such as poor performance and lack of standardisation (OIE 2000) . At present, application of the ELISA technique is considered a better test in early detection of infection than complement fixation test (Rojax and Alonso 1995). Indirect enzyme linked immunosorbent assays (I-ELISAs) have been developed and used in various countries for sero-diagnosis of brucellosis in cattle and other animals (Omer et al. 2001; Dajer et al. 1998; Molnar et al. 1998; Romero et al. 1995) , however, such kind of work in buffaloes is limited (Guarino et al. 2001) .
The incidence of brucellosis in Pakistan is increasing particularly in large dairy herds. Earlier studies indicated low prevalence, i.e., 0.33 to 0.65% (Sheikh et al. 1967) , whereas much higher prevalence is reported in recent studies, i.e., 21.05 to 26.1% (Sarwar 2000; Ramzan 1996; Akhtar et al. 1990 ). The incidence is higher in animals kept at organized farms rather than small holdings (Ahmad and Munir 1995; Lodhi et al. 1995; Ahmad et al. 1990 Ahmad et al. , 1994 . In spite of such a high incidence, none of the diagnostic tests has been standardised in buffaloes, therefore, in the present study an I-ELISA was developed using lipopolysaccharide (LPS) as antigen and compared with a commercial kit for the diagnosis of brucellosis in buffaloes.
Materials and Methods

Blood samples
One hundred negative serum samples were collected from buffaloes kept at a Livestock Research Station (LRS), National Agricultural Research Centre (NARC), having no previous history of brucellosis. These animals were tested twice a year regularly against brucellosis by RBPT. Another 100 serum samples were collected from buffaloes at a farm with clinical and serological evidence of the disease and history of abortions. The disease was confirmed by isolating Brucella abortus from the vaginal secretions of aborting animals, from the placenta and from the abomasum of the foetuses.
Serological tests
All the sera were tested for the presence of Brucella abortus antibodies by a commercial kit (CHEKIT ® , Germany) and a home-made kit. I-ELISA performed by the commercial kit is designated as I-ELISA com and home-made as I-ELISA dev.
Indirect ELISA (I-ELISA dev ) Bacterial strain cultivation and antigen extraction Brucella abortus strain 99 obtained from Germany was mass cultivated on tryptone soy agar (Oxoid Ltd, Basingstoke, Hampshire, England) slants and incubated at 37 °C for 24 to 48 h. After confirmation by Gram staining the bacterial growth was re-suspended in phosphate buffered saline (PBS, pH 6.4) and inoculated in Roux flasks containing tryptone soy agar and incubated for 48 h at 37 °C. Again, purity was checked by Gram staining and purified growth of the flasks were washed with 50 to 60 ml of phenolic saline and centrifuged at 10,000 g for 30 min to obtain the bacterial mass.
Smooth lipopolysaccharide (LPS) from Brucella abortus was extracted by hot phenol method (OIE 2004; Biancifiori et al. 1996) . Briefly, 50 g packed wet cells were re-suspended in distilled water at 66 C, followed by addition of 90% phenol with continuous stirring for 20 min in a shaking water bath with the same temperature. This mixture was centrifuged at 10,000 g and the bottom brownish phenol layer was removed and filtered (Wattman filter No.1). The LPS were precipitated by cold methanol, saturated with sodium acetate and centrifuged at 10,000 g for 10 min. The precipitates were separated and stirred with distilled water for 18 h followed by centrifugation at 10,000 g. The supernatant was kept at 4 C. The precipitates were re-suspended in distilled water and stirred for additional 2 h at 4 C. The supernatant was recovered by centrifugation as above and pooled with the previously recovered supernatant. Eight ml of trichloroacetic acid were added to the crude LPS (supernatant). After stirring for 10 min, the precipitates were removed by centrifugation and the translucent supernatant solution was dialyzed against distilled water. The quantity of smooth LPS in the antigen was determined by thiobarbituric assay (Waravdekar and Saslaw 1959) using purified 2-ket-3deoxyoctonate standard (Sigma, KDO catalog No. K7000).
I-ELISA dev procedure Indirect ELISA was standardised by the checkerboard titration method as described by Wright et al. (1993) . Brucella LPS antigen was diluted in carbonate coating buffer to a concentration as determined by checkerboard titration, i.e. 1.25 µg/ml. For coating, 100 µl of diluted antigen was added to each well of flat bottom microtitration plates (Titertek, Flow Laboratories, ) and incubated for 18 h at 4 C. The plates were washed five times with phosphate buffer saline tween-20 (PBST). All the sera were diluted 1 : 50 in PBST and 100 µl of the diluted sera was dispensed in each well of the micro-titration plate and incubated for one hour at 37 C.
After another washing cycle with PBST, 10 µl of diluted rabbit anti-bovine IgG whole molecule conjugated to horseradish peroxidase (Cappel, USA) diluted 1 : 1000 was added to all the wells of micro-titration plate followed by another 60 min of incubation at 37 C. After the washing cycle, 100 µl of substrate (2.2′ azino diethyl benzothiazoline sulfonic acid / ABTS) solution was added into each well of ELISA plate and incubated with shaking for 15 min at 37 C. The reaction was stopped by the addition of 100 µl of 4% SDS solution. Development of colour was assessed by a spectrophotometer (BDSL, Immunoskan MS) at 405 nm. Standard positive and negative serum controls were also included in each plate.
Data analysis Indirect ELISA
Provided the controls were within acceptable limits, the results were expressed in percent positivity (PP) which was calculated as follows (FAO/IAEA 1991): PP: Mean OD of duplicate tests × 100 / Mean OD of C++ control Sensitivity and specificity Relative sensitivity and specificity was calculated as (Thrusfield 1986):
Relative sensitivity (%): Total number of Positive results × 100 / Total number of positive animals sampled Relative specificity (%): Total number of negative results × 100 / Total number of negative animals sampled Scatter plot was used for the descriptive analysis of PI values. Kappa statistics applied for the measurement of agreement between both I-ELISA kit and I-ELISA dev, while Receiver Operating Characteristics (ROC) graph was plotted for cut off selection at its best accuracy. All analyses were conducted using the statistical software SPSS.
Results
The data frequency distribution of percent positive values in home-developed I-ELISA for detecting anti-Brucella antibodies in bovines is shown in Fig. 1 .
The distribution of percent positive values of home-developed I-ELISA for detecting anti-Brucella antibodies in bovines is shown in Fig. 2 .
Receiver Operating Characteristics (ROC) graph for the comparison of home developed and commercial I-ELISA for detection of Brucella antibodies in bovines is shown in Fig. 3 .
The agreement for the positive result between the I-ELISA dev and I-ELISA kit was 78% and for the negative it was 100%. Remaining 22% sera were positive by the I-ELISA dev and negative by the I-ELISA kit. Results of home-developed and commercial kit I-ELISA for detection of antibodies against bovine brucellosis are shown in contingency Table 1. At 52.49%, 53.09%, 53.26%, 53.86% and 53.94% cut off the sensitivity was 100%, 100%, 97.53%, 88.93% and 86.42%, while the specificity was 84.03%, 84.87%, 85.71%, 87.39% and 87.39%, respectively, for I-ELISA dev . The relative sensitivity and specificity of I-ELISA dev for detection of antibodies against bovine brucellosis at various cut offs is shown in Table 2 .
Discussion
In the present study, the LPS were used for the development of I-ELISA and this test was compared with commercial ELISA kit. The LPS were used because Brucella LPS has been considered the most important antigen during immune response and are the target for many serological and immunological studies. Also LPS can be extracted easily, quantified and standardised as compared to other antigens. Moreover, it gives better sensitivity and specificity with good reproducibility. It also possesses a convenient cut off value for diagnostic purposes. Finally, it is not restricted to bovine cattle and can be adapted to different species of animals as well as to humans. In addition, a small quantity is required for the screening of a large number of samples. However, by using LPS the specificity was slightly lower than the specificity (99.2%) observed by Abalos et al. (2000) when using the same antigen. This may be due to a lower number of samples tested by I-ELISA and the use of polyclonal anti-bovine IgG in our studies.
The relative sensitivity of I-ELISA dev was comparable with I-ELISA kit , whereas the specificity was a little bit compromised. This developed test can be used for the screening of herds, as the relative sensitivity is higher. In developing countries like Pakistan with a need for screening herds it can be used as a tool for screening purposes. Different researchers have described various reasons for the higher sensitivity of I-ELISA. According to Guarino et al. (2001) , the high percentage of positivity was due to the ability of this test to detect very low levels of antibodies present in the early stage of infection, while RBPT and SAT cannot detect it. The use of smooth LPS as antigen in the I-ELISA dev might be one of the reasons for higher sensitivity as the stronger immune responses are elicited against LPS in infected animals.
In a campaign for the control of a disease like brucellosis, it is desirable that the screening test is reliable and detects almost all positive cases in a herd. In our studies, I-ELISA dev detected equal positive samples as I-ELISA kit .
The main purpose of this study was the standardisation of I-ELISA to detect anti-Brucella antibodies in buffalo sera and its comparison with the commercial kit. In this study, the I-ELISA dev proved to be equally sensitive as I-ELISA kit . This standardized I-ELISA could be a useful diagnostic test for detection of Brucella antibodies. Moreover, the developed technique would be particularly useful for a region where little epidemiological information is available about this disease.
Nepřímý ELISA test v diagnóze brucelózy u buvolů
Brucelóza je významná zoonóza, která celosvětově způsobuje závažné ekonomické ztráty. Včasná diagnostika onemocnění je pro její kontrolu a eradikaci zásadní. Nyní byl vyvinut nepřímý ELISA test (Indirect Enzyme Linked Immunosorbent Assay, I-ELISA) s využitím lipopolysacharidu (LPS) jako antigenu a porovnán s komerčním kitem s využitím 100 negativních a 100 pozitivních sér buvolů. Počet shodně pozitivních výsledků mezi komerčním a vyvinutým I-ELISA testem byl 78 %. Negativní výsledky se shodovaly 
